Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Adalimumab in the Treatment of Chronic Pouchitis (ADAP)

This study has been completed.
Sponsor:
Collaborators:
University of Southern Denmark
Hvidovre University Hospital
Aarhus University Hospital
AbbVie
Information provided by (Responsible Party):
Mie Dilling Kjaer, Odense University Hospital
ClinicalTrials.gov Identifier:
NCT01670240
First received: August 8, 2012
Last updated: January 27, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2016
  Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)